Author details

Full Name

Jay A Nelson

Affiliation

Oregon Health and Science University

ORCID

Career Start Year

1978

Papers

212

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36700640	Virology under the Microscope-a Call for Rational Discourse.	J Virol	2023
37289831	Human cytomegalovirus UL138 interaction with USP1 activates STAT1 in infection.	PLoS Pathog	2023
36798153	Human Cytomegalovirus UL138 Interaction with USP1 Activates STAT1 in infection.	bioRxiv	2023
36700653	Virology under the Microscope-a Call for Rational Discourse.	mSphere	2023
36700642	Virology under the Microscope-a Call for Rational Discourse.	mBio	2023
35714200	Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.	Sci Immunol	2022
33177198	CD34<sup>+</sup> Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.	J Virol	2021
33766849	Cytomegaloviral determinants of CD8[+] T cell programming and RhCMV/SIV vaccine efficacy.	Sci Immunol	2021
33824207	Human Cytomegalovirus miR-US25-1 Targets the GTPase RhoA To Inhibit CD34<sup>+</sup> Hematopoietic Progenitor Cell Proliferation To Maintain the Latent Viral Genome.	mBio	2021
32268565	Human Cytomegalovirus Infection Suppresses CD34<sup>+</sup> Progenitor Cell Engraftment in Humanized Mice.	Microorganisms	2020
31866424	Human Cytomegalovirus miRNAs Regulate TGF-Î² to Mediate Myelosuppression while Maintaining Viral Latency in CD34<sup>+</sup> Hematopoietic Progenitor Cells.	Cell Host Microbe	2020
32759334	Human Cytomegalovirus miR-US5-2 Downregulation of GAB1 Regulates Cellular Proliferation and <i>UL138</i> Expression through Modulation of Epidermal Growth Factor Receptor Signaling Pathways.	mSphere	2020
31431555	Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34[+] Hematopoietic Progenitor Cells and Humanized NSG Mice.	mBio	2019
31725811	Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency.	PLoS Pathog	2019
31725809	HCMV miR-US22 down-regulation of EGR-1 regulates CD34+ hematopoietic progenitor cell proliferation and viral reactivation.	PLoS Pathog	2019
31848362	Characterization of a live-attenuated HCMV-based vaccine platform.	Sci Rep	2019
29343712	Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology.	Nat Commun	2018
29691342	Human Cytomegalovirus Encodes a Novel FLT3 Receptor Ligand Necessary for Hematopoietic Cell Differentiation and Viral Reactivation.	mBio	2018
28636599	Addendum: Immune clearance of highly pathogenic SIV infection.	Nature	2017
28278237	Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.	PLoS Pathog	2017
28380070	Correction: Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.	PLoS Pathog	2017
28428537	Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice.	Sci Rep	2017
28270578	Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-ÎºB-Activating Factors through Direct Downregulation of IKKÎ± and IKKÎ².	mBio	2017
29082387	Modulation of the NFÎºb Signalling Pathway by Human Cytomegalovirus.	Virology (Hyderabad)	2017
26797147	Broadly targeted CD8âº T cell responses restricted by major histocompatibility complex E.	Science	2016
27829026	Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus Macaques.	PLoS Pathog	2016
26933055	Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency.	mBio	2016
25955717	Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFÎºB Signaling Pathway.	PLoS Pathog	2015
26118890	Humanized mouse models of human cytomegalovirus infection.	Curr Opin Virol	2015
24161922	HCMV infection of humanized mice after transplantation of G-CSF-mobilized peripheral blood stem cells from HCMV-seropositive donors.	Biol Blood Marrow Transplant	2014
25352622	Human cytomegalovirus-encoded pUL7 is a novel CEACAM1-like molecule responsible for promotion of angiogenesis.	mBio	2014
24769092	Cytomegalovirus microRNAs.	Curr Opin Virol	2014
24599995	Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.	J Virol	2014
24639227	Techniques for characterizing cytomegalovirus-encoded miRNAs.	Methods Mol Biol	2014
24629342	Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion.	Cell Host Microbe	2014
24389009	Transcriptome-wide discovery of microRNA binding sites in human brain.	Neuron	2014
23704576	Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.	Science	2013
23824813	Flaviviruses are sensitive to inhibition of thymidine synthesis pathways.	J Virol	2013
23816389	Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis.	Curr Opin Virol	2013
24025770	Immune clearance of highly pathogenic SIV infection.	Nature	2013
22305624	Rhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo.	Virology	2012
21562493	Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.	Nature	2011
22241980	A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection.	PLoS Pathog	2011
22072961	BST2/Tetherin enhances entry of human cytomegalovirus.	PLoS Pathog	2011
21795337	Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.	J Virol	2011
21900172	Human cytomegalovirus US7 is regulated synergistically by two virally encoded microRNAs and by two distinct mechanisms.	J Virol	2011
20032184	A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells.	J Virol	2010
20833379	Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.	Cell Host Microbe	2010
20973722	High-content assay to identify inhibitors of dengue virus infection.	Assay Drug Dev Technol	2010
20585629	A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs.	PLoS Pathog	2010

1 - 50 of 212

Toni M Schwarz

Icahn School of Medicine at Mount Sinai

Career Start Year 2009

Number of shared co-authors 2

Travis J Chapa

David Geffen School of Medicine, University of California los angeles

Career Start Year 2006

Number of shared co-authors 0

Eleonora Forte

Northwestern University Feinberg School of Medicine

Career Start Year 2004

Number of shared co-authors 0

Edward P Browne

University of North Carolina at Chapel Hill

Career Start Year 2000

Number of shared co-authors 1

Renate K??nig

Paul-Ehrlich-Institut

Career Start Year 1998

Number of shared co-authors 9

J??rgen Haas

University of Edinburgh

Career Start Year 1996

Number of shared co-authors 2

Hongyu Deng

Cancer Research Institute, Central South University

Career Start Year 1995

Number of shared co-authors 1

Laurent Coscoy

University of California Berkeley

Career Start Year 1993

Number of shared co-authors 3

Domenico Tortorella

Icahn School of Medicine at Mount Sinai

Career Start Year 1993

Number of shared co-authors 8

Paul D Bieniasz

The Rockefeller University

Career Start Year 1993

Number of shared co-authors 8

Lubbertus C F Mulder

Icahn School of Medicine at Mount Sinai

Career Start Year 1993

Number of shared co-authors 7

John W Barrett

University of Western Ontario

Career Start Year 1992

Number of shared co-authors 0

Ren Sun

University of California los angeles

Career Start Year 1992

Number of shared co-authors 4

Vicente Planelles

University of Utah

Career Start Year 1991

Number of shared co-authors 5

Keith R Jerome

Fred Hutchinson Cancer Center

Career Start Year 1991

Number of shared co-authors 3

Pavel Sova

Altius Institute for Biomedical Sciences

Career Start Year 1990

Number of shared co-authors 9

P Robert Beatty

School of Public Health, University of California berkeley

Career Start Year 1990

Number of shared co-authors 1

Olivier Schwartz

Institut Pasteur, Universite Paris Cite, CNRS UMR9

Career Start Year 1987

Number of shared co-authors 5

Mohan Somasundaran

University of Massachusetts Chan Medical School

Career Start Year 1985

Number of shared co-authors 1

Michael G Kurilla

National Center for Advancing Translational Sciences, National Institutes of Health

Career Start Year 1982

Number of shared co-authors 0

Rafick-Pierre Sekaly

Pathology Advanced Translational Research Unit, Emory University School of Medicine

Career Start Year 1981

Number of shared co-authors 9

Steven M Wolinsky

Northwestern University Feinberg School of Medicine

Career Start Year 1979

Number of shared co-authors 8

John Guatelli

University of California San Diego, USA VA San Diego Healthcare System

Career Start Year 1978

Number of shared co-authors 3

Boris Matija Peterlin

University of California at San Francisco

Career Start Year 1978

Number of shared co-authors 1

Wendy Maury

Carver College of Medicine, University of Iowa

Career Start Year 1978

Number of shared co-authors 0

Lenore Pereira

University of California san francisco

Career Start Year 1976

Number of shared co-authors 1

Robert F Garry

Tulane University School of Medicine

Career Start Year 1974

Number of shared co-authors 2

Ulrich H Koszinowski

Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen

Career Start Year 1973

Number of shared co-authors 2

Warner C Greene

Gladstone Institute of Virology, USA University of California san francisco

Career Start Year 1971

Number of shared co-authors 6

Eric Hunter

Center for Family Health Research Zambia

Career Start Year 1971

Number of shared co-authors 4

row(s) 1 - 30 of 30

Daniel N Streblow

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 44

Meaghan H Hancock

Vaccine and Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 20

Craig N Kreklywich

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 18

Peter Ghazal

UK System Immunity Research Institute, Cardiff University

Co-authored papers 17

Patrizia Caposio

Vaccine and Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 14

Louis J Picker

Vaccine and Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 13

Alec J Hirsch

Vaccine & Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 12

Felicia Goodrum

University of Arizona

Co-authored papers 12

Lindsey B Crawford

Vaccine and Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 11

Victor R DeFilippis

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 11

William J Britt

Heersink School of Medicine, University of Alabama at Birmingham

Co-authored papers 10

Finn Grey

The Roslin Institute, The University of Edinburgh

Co-authored papers 9

Heather L Meyers

Co-authored papers 8

Andrew D Yurochko

Louisiana State University

Co-authored papers 8

Igor Landais

Vaccine and Gene Therapy Institute, Oregon Health and Sciences University

Co-authored papers 7

Howard E Gendelman

Co-authored papers 7

Jeffrey D Lifson

Frederick National Laboratory

Co-authored papers 7

Lauren M Hook

Perelman School of Medicine, University of Pennsylvania

Co-authored papers 7

Jessica L Smith

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 7

Jay A Levy

Co-authored papers 6

Rodney Lee Mosley

Co-authored papers 5

Rebecca S Tirabassi

Vaccine and Gene Therapy Institute, Oregon Health & Sciences University

Co-authored papers 5

David A Stein

College of Veterinary Medicine, Oregon State University

Co-authored papers 4

Larisa Y Poluektova

Co-authored papers 4

David M Lewinsohn

Oregon Health and Science University

Co-authored papers 3

Mark T Heise

University of North Carolina at Chapel Hill.

Co-authored papers 3

Arturo Casadevall

Johns Hopkins Bloomberg School of Public Health

Co-authored papers 3

Viviana Simon

Icahn School of Medicine at Mount Sinai

Co-authored papers 3

Michael Denton

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 3

Andrew Pekosz

Co-authored papers 3

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators